Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

PET imaging in gynecologic malignancies.

Rakesh Kumar1, Abass Alavi

  • 1Division of Nuclear Medicine, Department of Radiology, Hospital of the University of Pennsylvania, 3400 Spruce Street, 110 Donner Building, Philadelphia, PA 19104, USA.

Radiologic Clinics of North America
|October 19, 2004
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

PET-Based Personalized Management in Clinical Oncology: An Unavoidable Path for the Foreseeable Future.

PET clinics·2016
Same author

Personalized Management Approaches in Lymphoma: Utility of Fluorodeoxyglucose-PET Imaging.

PET clinics·2016
Same author

Evolving Role of Molecular Imaging with (18)F-Sodium Fluoride PET as a Biomarker for Calcium Metabolism.

Current osteoporosis reports·2016
Same author

Ocular Melanoma and Other Unusual Sites.

PET clinics·2016
Same author

Other PET Tracers and Prospects for the Future.

PET clinics·2016
Same author

Normal Variants and Effects of Aging on the Gastrointestinal Tract.

PET clinics·2016
Same journal

Orbital Imaging.

Radiologic clinics of North America·2026
Same journal

Imaging, Management, and Treatment of Orbital Trauma.

Radiologic clinics of North America·2026
Same journal

Imaging Findings after Multidisciplinary Treatment for Orbital and Ocular Adnexal Cancers.

Radiologic clinics of North America·2026
Same journal

Orbital Tumors: What the Radiologist Needs to Know from the Orbital Surgeon's Perspective.

Radiologic clinics of North America·2026
Same journal

Multidisciplinary Management of Tumors of the Orbit.

Radiologic clinics of North America·2026
Same journal

Skull Base, Bone, Pituitary-Regions around Orbit that Affect Vision.

Radiologic clinics of North America·2026
See all related articles

Fluorodeoxyglucose-positron emission tomography (FDG-PET) effectively detects cancer spread and recurrence. Combined PET/CT imaging improves lesion localization, aiding clinical practice, especially in ovarian cancer.

Area of Science:

  • Nuclear Medicine
  • Oncology
  • Radiology

Background:

  • FDG-PET is valuable for detecting lymph node involvement and distant metastases.
  • Its role in assessing tumor recurrence and restaging shows promise but requires further validation for routine clinical use.

Purpose of the Study:

  • To evaluate the utility of FDG-PET in detecting cancer recurrence and metastases.
  • To assess the effectiveness of combined PET/CT in improving lesion localization and differentiating uptake.

Main Methods:

  • Review of studies on FDG-PET for cancer detection, recurrence, and restaging.
  • Analysis of FDG-PET performance in ovarian cancer, including sensitivity and specificity.
  • Evaluation of combined PET/CT for improved lesion localization and differentiation of physiologic uptake.

Related Experiment Videos

Main Results:

  • FDG-PET demonstrates a definite role in detecting lymph node involvement and distant metastases.
  • High sensitivity and specificity of FDG-PET in identifying recurrent ovarian cancer were observed.
  • Combined PET/CT enhances lesion localization and helps differentiate pathologic from physiologic uptake, particularly in the pelvis and abdomen.

Conclusions:

  • FDG-PET is effective for detecting metastases and has potential in assessing recurrence and restaging.
  • Combined PET/CT imaging is beneficial for improving lesion localization and diagnostic accuracy in oncology.
  • Further studies are needed to integrate FDG-PET into routine clinical practice for recurrence diagnosis.